Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
Launched by RUSH UNIVERSITY MEDICAL CENTER · Feb 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping South Asian Indian immigrant women improve their physical activity levels and overall health to reduce the risk of breast cancer. The study is looking for women aged 40 to 65 who do not have breast cancer and are currently not very active—meaning they do less than 150 minutes of moderate exercise or 75 minutes of vigorous exercise each week. Participants must speak Hindi, own a smartphone for using a Fitbit app, and be comfortable with online sessions that will be recorded. Women with certain health conditions, like severe diabetes or heart issues, may need medical clearance to join.
If you qualify for the study, you can expect to take part in virtual sessions where you'll learn about physical activity and how it can help prevent breast cancer. You'll also be using a Fitbit app to track your progress. This trial is not yet recruiting participants, but it aims to empower women to lead healthier lives through increased physical activity, which is an important step in preventing breast cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-identified first-generation SAI woman aged 40-65 years without breast cancer diagnosis (permanent residency in US or are in the process of obtaining permanent residency)
- • Insufficiently active (self-reported \<150 minutes/week of moderate-intensity or \<75 minutes/week of vigorous-intensity PA in the past month)
- • Conversant in Hindi
- • Owns a smartphone for Fitbit application
- • Has a computer or mobile device with Internet access
- • Willing to participate in recorded Virtual intervention sessions
- • Medical clearance if has Type 1 diabetes, or Type 2 diabetes with an A1C ≥ 9.0%, or have an A1C of ≥ 6.5% without a prior diabetes diagnosis
- • Has no disabilities preventing regular PA determined by Physical Activity Readiness Questionnaire (PAR-Q \& You)
- Exclusion Criteria:
- • Major signs/symptoms of pulmonary or CVD, unstable cardiac or pulmonary disease in the past month, or other conditions interfering with walking (per PAR-Q \& You)
- • Systolic BP ≥160 and/or diastolic BP ≥100
About Rush University Medical Center
Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Manju Daniel, PhD
Principal Investigator
Rush University College of Nursing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported